|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reuss D and von Deimling A: Hereditary
tumor syndromes and gliomas. Recent Results Cancer Res. 171:83–102.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Riezzo I, Zamparese R, Neri M, De Stefano
F, Parente R, Pomara C, Turillazzi E, Ventura F and Fineschi V:
Sudden, unexpected death due to glioblastoma: Report of three fatal
cases and review of the literature. Diagn Pathol. 8:732013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swanson KD, Lok E and Wong ET: An overview
of alternating electric fields therapy (NovoTTF Therapy) for the
treatment of malignant glioma. Curr Neurol Neurosci Rep. 16:82016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sareddy GR, Panigrahi M, Challa S,
Mahadevan A and Babu PP: Activation of Wnt/beta-catenin/Tcf
signaling pathway in human astrocytomas. Neurochem Int. 55:307–317.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schüle R, Dictus C, Campos B, Wan F,
Felsberg J, Ahmadi R, Centner FS, Grabe N, Reifenberger G, Bermejo
JL, et al: Potential canonical wnt pathway activation in high-grade
astrocytomas. ScientificWorldJournal. 2012:6973132012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Huang K, Shi Z, Zou J, Wang Y,
Jia Z, Zhang A, Han L, Yue X, Liu N, et al: High β-catenin/Tcf-4
activity confers glioma progression via direct regulation of AKT2
gene expression. Neuro Oncol. 13:600–609. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kikuchi A: Canonical Wnt signaling pathway
and cellular responses. Clin Calcium. 23:799–807. 2013.(In
Japanese). PubMed/NCBI
|
|
11
|
Chen L, Huang K, Han L, Shi Z, Zhang K, Pu
P, Jiang C and Kang C: β-catenin/Tcf-4 complex transcriptionally
regulates AKT1 in glioma. Int J Oncol. 39:883–890. 2011.PubMed/NCBI
|
|
12
|
Travis A, Amsterdam A, Belanger C and
Grosschedl R: LEF-1, a gene encoding a lymphoid-specific protein
with an HMG domain, regulates T-cell receptor alpha enhancer
function [corrected]. Genes Dev. 5:880–894. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van de Wetering M, Oosterwegel M, Dooijes
D and Clevers H: Identification and cloning of TCF-1, a T
lymphocyte-specific transcription factor containing a
sequence-specific HMG box. EMBO J. 10:123–132. 1991.PubMed/NCBI
|
|
14
|
Shiina H, Igawa M, Breault J,
Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M,
Yamanaka M, Shirai M, et al: The human T-cell factor-4 gene
splicing isoforms, Wnt signal pathway, and apoptosis in renal cell
carcinoma. Clin Cancer Res. 9:2121–2132. 2003.PubMed/NCBI
|
|
15
|
Tsedensodnom O, Koga H, Rosenberg SA,
Nambotin SB, Carroll JJ, Wands JR and Kim M: Identification of
T-cell factor-4 isoforms that contribute to the malignant phenotype
of hepatocellular carcinoma cells. Exp Cell Res. 317:920–931. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duval A, Rolland S, Tubacher E, Bui H,
Thomas G and Hamelin R: The human T-cell transcription factor-4
gene: Structure, extensive characterization of alternative
splicings, and mutational analysis in colorectal cancer cell lines.
Cancer Res. 60:3872–3879. 2000.PubMed/NCBI
|
|
17
|
Howng SL, Huang FH, Hwang SL, Lieu AS, Sy
WD, Wang C and Hong YR: Differential expression and splicing
isoform analysis of human Tcf-4 transcription factor in brain
tumors. Int J Oncol. 25:1685–1692. 2004.PubMed/NCBI
|
|
18
|
He G, Guan X, Chen X, Wang Y, Luo C and
Zhang B: Expression and splice variant analysis of human TCF4
transcription factor in esophageal cancer. J Cancer. 6:333–341.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu X, Yao L, Ma G, Cui L, Li Y, Liang W,
Zhao B and Li K: TCTP promotes glioma cell proliferation in vitro
and in vivo via enhanced β-catenin/TCF-4 transcription. Neuro
Oncol. 16:217–227. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wallmen B, Schrempp M and Hecht A:
Intrinsic properties of Tcf1 and Tcf4 splice variants determine
cell-type-specific Wnt/β-catenin target gene expression. Nucleic
Acids Res. 40:9455–9469. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomimaru Y, Koga H, Yano H, de la Monte S,
Wands JR and Kim M: Upregulation of T-cell factor-4
isoform-responsive target genes in hepatocellular carcinoma. Liver
Int. 33:1100–1112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clevers H and van de Wetering M: TCF/LEF
factor earn their wings. Trends Genet. 13:485–489. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Duval A, Gayet J, Zhou XP, Iacopetta B,
Thomas G and Hamelin R: Frequent frameshift mutations of the TCF-4
gene in colorectal cancers with microsatellite instability. Cancer
Res. 59:4213–4215. 1999.PubMed/NCBI
|
|
24
|
Barker N: The canonical Wnt/beta-catenin
signalling pathway. Methods Mol Biol. 468:5–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Micalizzi DS and Ford HL:
Epithelial-mesenchymal transition in development and cancer. Future
Oncol. 5:1129–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
